The main functions and applications of enzalutamide/enzalutamide (Anchortan) soft capsules
Enzalutamide/Enzalutamide ( Enzalutamide) soft capsules, as a new generation of androgen receptor inhibitors, occupy an important position in the global treatment of prostate cancer. Its function is to block the androgen receptor signaling pathway through multiple links, thereby inhibiting the androgen-dependent growth of tumor cells. This pharmacological method is not just a simple receptor blockade, but also reduces the binding ability of androgens to receptors, inhibits the transfer of receptors to the nucleus, and reduces the transcriptional activity of downstream genes, preventing cancer cells from completing the normal proliferation process. Therefore, it has long been regarded as one of the key anti-tumor endocrine drugs in overseas guidelines.
The scope of application of enzalutamide soft capsules mainly involves different stages of prostate cancer, especially patients who have insufficient response to traditional endocrine therapy. Its indications span from non-metastatic castration-resistant stage to advanced disease with distant metastasis, and can be used together with androgen deprivation therapy to enhance the overall intensity of inhibiting tumor progression. This cross-stage use feature makes it extremely flexible in the current clinical path. Whether the disease has just entered the drug-resistant stage or has already spread systematically, treatment plans can be added after doctor evaluation.
The dosage form of enzalutamide is a soft capsule, which means that it is absorbed more smoothly and is convenient to take. At the same time, it can reduce some gastrointestinal irritation, which meets the actual needs of long-term medication. Due to its long half-life, the drug concentration in the body can be maintained stable, so taking it at a fixed time every day can achieve the purpose of continuous suppression. Overseas information emphasizes that its central penetrating ability is strong, so some patients may experience fatigue, decreased attention, etc., but this is also a manifestation of its deep suppression of AR signals.
Reference materials:https://www.xtandi.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)